Universität zu Köln

Mallmann, M. R. and Mallmann, P. (2017). Systemic therapy for endometrial cancer. Onkologe, 23 (1). S. 34 - 37. NEW YORK: SPRINGER. ISSN 1433-0415

Full text not available from this repository.

Abstract

The decision on adjuvant systemic therapy for endometrial cancer is based on the clinicopathological risk factors. A selective literature review and analysis of the current guideline recommendations were carried out. In the low-risk situation no adjuvant treatment is necessary after surgery but in medium risk patients adjuvant radiotherapy is indicated after surgery. In the high-risk situation, such as advanced carcinoma systemic chemotherapy with carboplatin-paclitaxel should be carried out. In palliative care situations a gestagen-based therapy should be considered. Due to frequent comorbidities, the risks and benefits should be carefully considered in each individual case.

Item Type:	Journal Article
Creators:	Creators Email ORCID ORCID Put Code Mallmann, M. R. UNSPECIFIED UNSPECIFIED UNSPECIFIED Mallmann, P. UNSPECIFIED UNSPECIFIED UNSPECIFIED
URN:	urn:nbn:de:hbz:38-247901
DOI:	10.1007/s00761-016-0129-y
Journal or Publication Title:	Onkologe
Volume:	23
Number:	1
Page Range:	S. 34 - 37
Date:	2017
Publisher:	SPRINGER
Place of Publication:	NEW YORK
ISSN:	1433-0415
Language:	German
Faculty:	Unspecified
Divisions:	Unspecified
Subjects:	no entry
Uncontrolled Keywords:	Keywords Language GYNECOLOGIC-ONCOLOGY-GROUP; CARCINOMA; CHEMOTHERAPY; ACETATE Multiple languages Oncology Multiple languages
Refereed:	Yes
URI:	http://kups.ub.uni-koeln.de/id/eprint/24790